Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy
- 3 November 2024
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1879 (6) , 189207
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82074069, 2060302)
This publication has 137 references indexed in Scilit:
- LncRNA‐CCAT5‐mediated crosstalk between Wnt/β‐Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activityCancer Communications, 2023
- YAP/STAT3 inhibited CD8+ T cells activity in the breast cancer immune microenvironment by inducing M2 polarization of tumor‐associated macrophagesCancer Medicine, 2023
- STAT3 pathway in cancers: Past, present, and futureMedcomm, 2022
- MicroRNA‐124‐3p suppresses PD‐L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signalingJournal of Cellular Physiology, 2021
- Mitochondrial STAT3 regulates antioxidant gene expression through complex I‐derived NAD in triple negative breast cancerMolecular Oncology, 2021
- miR‐223 improves intestinal inflammation through inhibiting the IL‐6/STAT3 signaling pathway in dextran sodium sulfate‐induced experimental colitisImmunity, Inflammation and Disease, 2020
- MicroRNA216b mediated downregulation of HSP27/STAT3/AKT signaling is critically involved in lambertianic acid induced apoptosis in human cervical cancersPhytotherapy Research, 2020
- Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3International Journal of Cancer, 2019
- Toll‐like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2International Journal of Cancer, 2018
- Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating Glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alphaHepatology, 2012